Sunday, March 4, 2012

Studies from GlaxoSmithKline describe new findings in melanoma.

"Abnormal expression of major histocompatibility complex l molecules in melanoma has been reported previously. However, the MHC molecule expression patterns in different growth phases of melanoma and the underlying mechanisms are not well understood," investigators in the United States report (see also Melanoma).

"Here, we demonstrate that in vertical growth phase (VGP) melanomas, MHC genes are subject to increased rates of DNA copy number gains, accompanied by increased expression, in comparison to normal melanocytes. In contrast, MHC expression in metastatic melanomas drastically decreased compared to VGP melanomas, despite still prevalent DNA copy number gains. Subsequent …

No comments:

Post a Comment